T

Tarsus Pharmaceuticals
D

TARS

47.840
USD
-0.92
(-1.89%)
مغلق
حجم التداول
15,229
الربح لكل سهم
-1
العائد الربحي
-
P/E
-13
حجم السوق
1,828,776,283
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Tarsus Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.